Clinical trials recruiting for Generalized Anxiety Disorder (GAD)
15
Recruiting trials
23
US states with sites
8
Countries
13%
Accept healthy volunteers
Phase breakdown
Phase 2 2Phase 3 1Not applicable 12
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| ABBV-932 | 1 |
| Antidepressant Therapy (ADT) | 1 |
| Low-Dose Cannabidiol | 1 |
| Moderate-Dose Cannabidiol | 1 |
| Psilocybin (drug) | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Florida | 3 |
| Texas | 3 |
| California | 2 |
| Alabama | 1 |
| Arizona | 1 |
| Connecticut | 1 |
| Georgia | 1 |
| Illinois | 1 |
| Kansas | 1 |
| Maryland | 1 |
| Massachusetts | 1 |
| Michigan | 1 |
Top cities
Dallas, Texas 2Los Angeles, California 2Miami, Florida 2Allentown, Pennsylvania 1Anaheim, California 1Avon Lake, Ohio 1Bellevue, Washington 1Brooklyn, New York 1Charleston, South Carolina 1Charlotte, North Carolina 1
Self-screener
Recruiting trials
- An Examination of the Performance of QbMobile in Differential Diagnosis Associated With ADHD Symptoms
- Cannabidiol-Assisted Learning for Managing Generalized Anxiety Disorder
- EEG Study on Neurophysiological and Psychological Effects of Ericksonian Hypnotherapy in Generalized Anxiety Disorder
- Effectiveness of Solution-Focused Therapy for Generalized Anxiety Disorder in Emerging Adults
- LHC-CIDI-5 in Hong Kong
- Personalized AI-Driven Models in Cognitive Behavioral Therapy for Anxiety
- Safety, Tolerability, and Preliminary Efficacy of Psilocybin Oral Solution in Adults With Generalized Anxiety Disorder
- Stepped Care Treatment for Anxiety Resilience
- Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder
- Targeting Social Function in Anxiety and Eating Disorders
- Text Message Safety Behavior Fading for Pathological Worry
- The Effect of Patient Preference for Treatment Model in Internet Delivered Cognitive Behavior Therapy for Generalized Anxiety Disorder
- Transcranial Alternating Current Stimulation for Generalized Anxiety Disorder and Insomnia: An Open-Label Pilot Study
- Transdiagnostic Metacognitive Therapy Compared to Disorder-Specific Cognitive-Behavioral Therapy for Anxiety Disorders
- Validation of the CIDI 5.0 Against the SCID-5 for Lifetime Mental Disorders
Related conditions
Trials recruiting for Generalized Anxiety Disorder (GAD) often also study these conditions. Each links to its own recruiting-trial list.
Anxiety 1237Posttraumatic Stress Disorder (PTSD) 7Depression 1463Social Anxiety Disorder (SAD) 9Social Anxiety Disorder 35Separation Anxiety Disorder 4Obsessive Compulsive Disorder (OCD) 24Major depressive disorder 166Bipolar disorder 212Anxiety Disorders 75
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Generalized Anxiety Disorder (GAD) trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.